Apricus Biosciences Inc. ’s (APRI) share price has entered into oversold territory with an RSI value of 27.7. The Zacks Consensus Estimate on Apricus Biosciences Inc.’s earnings for the full year period has loss of 0.02 cents over the past two months to $-0.54 per share. Currently, Apricus Biosciences Inc. is a Zacks #2 Rank (“Buy”), suggesting that now might be a good time to get in on (APRI) after its recent drop.
APRICUS BIOSCIENCES INC (APRI): Free Stock Analysis Report
Zacks Investment Research